The Arkansas Supreme Court today overturned a $1.2 billion judgment against Johnson & Johnson, ruling that laws requiring companies to properly communicate risks and use of drugs applies to health care companies, not pharmaceutical companies. “I am disappointed that the Court viewed the law differently. Nevertheless, I will keep working to protect consumers against fraud and the kinds of irresponsible and greedy actions shown by Johnson & Johnson and Janssen Pharmaceuticals in their marketing of the drug Risperdal,” said Arkansas Attorney General Dustin McDaniel.
Of further interest:
Champagne around… (1BoringOldMan)
Arkansas Supreme Court reverses billion-dollar Risperdal case (Arkansas Blog)